Standardized mitotic counts in breast cancer evaluation of the method

Pathology Research and Practice

Volumn 192, Issue 9, 1996, Pages 931-941

  Collan, Y U I ^a   Kuopio, T ^a   Baak, J P A ^b   Becker, R ^g   Bogomoletz, W V ^h   Deverell, M ⁱ   Van Diest, P ^b   Van Galen, C ^b   Gilchrist, K ^c   Javed, A ⁱ   Kosma, V M ^d   Kujari, H ^a   Luzi, P ^j   Mariuzzi, G M ^e   Matze, E ^b   Montironi, R ^f   Scarpelli, M ^f   Sierra, D ^k   Sisti, S ^f   Toikkanen, S ^a   Tosi, P ^j   Whimster, W F ⁱ   Wisse, E ^b   more..

^a UNIVERSITY OF TURKU   (Finland)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF VERONA   (Italy)

^f UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^g ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^h INSTITUT JEAN GODINOT   (France)

ⁱ KING S COLLEGE HOSPITAL   (United Kingdom)

^j UNIVERSITY OF SIENA   (Italy)

^k HOSPITAL ESPAÑOL   (Argentina)

more..

Author keywords

Breast cancer; Grading efficiency; M V(V) index; MAI; Proliferative activity; SMI; Standardized mitotic index

Indexed keywords

PARAFFIN;

ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; EPITHELIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MITOSIS INDEX; OBSERVER VARIATION; PATHOLOGIST; PRODUCTIVITY; PROGNOSIS; REPRODUCIBILITY; TRAINING;

EID: 10544232622     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80075-6     Document Type: Article

References (35)

1. Aaltomaa S, Lipponen P, Eskelinen M, Kosma V-M, Mann S, Alhava E, Syrjänen K (1992) Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol 118: 75-81
2. Baak JPA (1990) Mitosis counting in rumors. Hum Pathol 23: 683-685
3. Baak JPA, Dop v. H, Kurver PHJ, Hermans JO (1985) The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374-382
4. Clayton F (1991) Pathologic correlates of survival in 378 lymph node-negative infiltrative ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68: 1309-1317
5. Collan Y: Reproducibility, the neglected cornerstone of medical diagnostics. In: Collan Y, Romppanen T (1982) Morphometry in morphological diagnosis, pp 5-21, Kuopio, Kuopio University Press
6. Collan Y (1989) General principles of grading lesions in diagnostic histopathology. Path Res Pract 185: 539-543
7. Collan Y (1992) Mitotic counts for grading and prognostication of cancer. Interpretation of volume corrected mitotic index. Acta Stereol 11 (Suppl) 1: 717-722
8. Collan Y, Haapasalo H (1991) The value of mitotic counting in the assessment of prognosis and proliferation in human tumours. J Pathol 163: 361-364
9. Collan Y, Klemi P, Kallioniemi O-P, Joensuu H, Nordling S, Eskelinen M (1992) Significance of variation in DNA flow cytometric analyses from paraffin-embedded breast cancers: an interlaboratory study. Evaluation of the grading efficiency of ploidy determination, DNA index and S phase fraction. Path Res Pract 188: 581-586
10. Collan Y, Kumpusalo L, Pesonen E, Eskelinen M, Pajarinen P, Kettunen K (1988) Predicrion of prognosis of breast cancer: Muitivariate analysis of mirotic index, lymph node status, and tumor size. Abstracts, XXI Nordic Congress on Pathology and Cytology, Oulu, June 20-23, 1988. Acta Universitatis Outuensis, Series D Medica 174: 8
11. Collan Y, Oja E, Whimster WE (1983) Mathematical background to stereology and morphometry for diagnostic pathologists. Acta Stereol 2: 214-238
12. Collan Y, Pesonen E (1989) Principles of morphometric grading. Gegenbaurs Morphol Jahrbuch 135: 13-17
13. Collan Y, Torkkeli T, Kosma V-M, Pesonen E, Kosunen O, Jantunen E, Montironi R, Marinelli F, Collina G (1987) Sampling in diagnostic morphometry: The influence of variation sources. Pathol Res Pract 182: 401-406
14. van Diest PJ, Baak JPA (1991) The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node -negative and lymph node -positive breast cancer patients. Hum Pathol 22: 236-330
15. van Diest PJ, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, van Galen CM, Kurver PHJ, Bellor SM, Fijnheer J, van Gorp LHM, Kwee WS, Los J, Pererse JL, Ruitenberg HM, Schapers RFM, Schipper MEI, Somsen JG, Willig AWPM, Ariens AT (1992) Reproducibility of mitosis counting in 2469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project. Hum Pathol 23: 603-607
16. Donhuijsen K, Schmidt U, Hirsche H, Budach V (1990) Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 21: 709-714
17. Downie NM, Heath RW (1974) Basic statistical methods. 4th Ed. Harper & Row Publishers, New York
18. Ellis PSJ, Chir B, Whitehead R (1981) Mitosis counting - a need for reappraisal. Hum Pathol 12: 3-4
19. 1? Going JJ (I 993) Techniques of mitosis counting. Hum Pathol 24: 113-114
20. Haapasalo H, Pesonen E, Collan Y (1989) Volume corrected mitotic index (M/V index). The standard of mitotic activity in neoplasms. Path Res Pract 185: 551-554
21. Hall PA, Levison DA (1991) Review: Assessment of cell proliferation in histological material. J Clin Pathol 43: 184-192
22. Isola JJ, Helin J, Helle MJ, Kallioniemi O-P (1990) Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer 65: 1180-1184
23. Kosma V-M, Collan Y, Kulju T, Aalto M-L, Jantunen E, Karhunen J, Selkäinaho K (1985) Reproducibility and variation of morphometric analysis of carcinoembryonic antigen staining in histopathology. The influence of standardized microscopic fields. Anal Quant Cytol Histol 7: 271-274
24. Kujari HP, Collan YUI, Atkin NB (1994) Use of the mitotic counts for the prognosis and grading of breast cancer. Method evaluation study. Path Res Pract 190: 593-599
25. Laroye GJ, Minkin S(1991) The impact of mitotic index on predicting outcome in breast carcinoma: A comparison of different counting methods in patients with different lymph node status. Mod Pathol 4: 456-460
26. Meyer JS, McDivitt RW (1986) Reliability and stability of the thymtdine labelling index of breast carcinoma. Lab Invest 54: 160-164
27. Montironi R, Collan Y, Scarpelli M, Sisti S, Barbatelli G, Carnevali A, Pisani E, Mariuzzi GM (1988) Reproducibility of mirotic counts and identification of mitotic figures in malignant glial tumors. Appl Pathol 6: 258-265
28. Page DL, Dupont WD, Dutt PL, Simpson J (1993) Reply to JJ Going's letter. Hum Pathol 24: 114
29. Quinn CM, Wright NA (1990) The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 160: 93-102
30. Selkäinaho K (1983) Statistics in stereology and morphometry. Acta Stereol 2: 239-249
31. Silvestrini R (1991) Feasibility and reproducibility of the [+ 3H]-thymidine labelling index in breast cancer. Cell Proliferation 24: 437-445
32. Simpson JF, Dutt PL, Page DL (1992) Expression of mitoses per thousand cells and cell density in breast carcinoma. A proposal. Hum Pathol 23: 608-611
33. Thornton JG, Wells M, Hume WJ (1989) Measurement of the S-phase duration in normal and abnormal human endometrium by in vitro double labelling with bromodeoxyuridine and tritiated thymidine. J Pathol 157: 109-115
34. Weibel ER (1979) Stereological methods. Vol. 1. Practical methods for biological morphometry. Academic Press, London
35. Woosley JT (1991) Measuring cell proliferation. Arch Pathol Lab Med 115: 555-557